Position in AMGN
as of Jun 30, 2026
· filed Aug 20, 2026
Position Value
$2,202,775
+$135,305 QoQ
Shares Held
6,083
+3.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.26%
of 13F equity value
Holder Rank
#1,233
of 3,149 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Rehmann Capital Advisory Group holds $37,318,224 across 12 Drug Manufacturers - General names. AMGN ranks #7 (5.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
38,703 | $9,829,400 | |
| 2 | LLY |
ELI LILLY & Co
|
5,246 | $6,292,210 | |
| 3 | MRK |
Merck & Co., Inc.
|
29,611 | $3,805,013 | |
| 4 | PFE |
Pfizer Inc
|
152,066 | $3,661,749 | |
| 5 | ABBV |
AbbVie Inc.
|
12,987 | $3,268,048 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
42,344 | $2,439,861 | |
| 7 | AMGN |
Amgen Inc
This page
|
6,083 | $2,202,775 | |
| 8 | AZN |
Astrazeneca PLC
|
10,283 | $1,949,862 |
All Filings in AMGN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,202,775 | 6,083 | Shares | Sole | 2026-08-20 | |
| 2026-03-31 | $2,067,470 | 5,876 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,867,958 | 5,707 | Shares | Sole | 2026-03-04 | |
| 2025-09-30 | $1,694,046 | 6,003 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $2,495,299 | 8,937 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $2,805,819 | 9,006 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $2,207,881 | 8,471 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $2,694,320 | 8,362 | Shares | Sole | 2024-11-18 | |
| 2024-06-30 | $2,606,457 | 8,342 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $2,426,671 | 8,535 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $2,407,559 | 8,359 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $2,171,849 | 8,081 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,524,611 | 6,867 | Shares | Sole | 2023-08-23 | |
| 2023-03-31 | $1,636,164 | 6,768 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $1,663,561 | 6,334 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $1,412,581 | 6,267 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,433,037 | 5,890 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $1,581,986 | 6,542 | Shares | Sole | 2022-06-03 | |
| 2021-12-31 | $1,164,669 | 5,177 | Shares | Sole | 2022-03-02 | |
| 2021-09-30 | $1,202,748 | 5,656 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $1,367,681 | 5,611 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $1,364,971 | 5,486 | Shares | Sole | 2021-05-26 | |
| 2020-12-31 | $1,202,941 | 5,232 | Shares | Sole | 2021-02-19 | |
| 2020-09-30 | $1,227,592 | 4,830 | Shares | Sole | 2020-11-19 | |
| 2020-06-30 | $1,119,155 | 4,745 | Shares | Sole | 2020-11-20 | |
| No filing history on record for this holder in this stock. | ||||||